Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lydia Lee

Showing results (41-50 of 57) with videos related to

Pageof 6
Sort By:
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|June 3, 2022
The impact of COVID-19 on autologous stem cell transplantation in multiple myeloma: A single-centre, qualitative evaluation studyMarquita Camilleri, Georgios Bekris, Govundeep Sidhu, et al.
British Journal of Haematology|June 18, 2016
Evaluation of B cell maturation antigen as a target for antibody drug conjugate mediated cytotoxicity in multiple myelomaLydia Lee, Danton Bounds, Jennifer Paterson, et al.
Frontiers in Oncology|August 9, 2021
Defining Unmet Need Following Lenalidomide Refractoriness: Real-World Evidence of Outcomes in Patients With Multiple MyelomaCatherine S Y Lecat, Jessica B Taube, William Wilson, et al.
Frontiers in Immunology|March 15, 2021
Increased Immune-Regulatory Receptor Expression on Effector T Cells as Early Indicators of Relapse Following Autologous Stem Cell Transplantation for Multiple MyelomaLydia Lee, Nouf Alrasheed, Garima Khandelwal, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|July 2, 2024
The impact of continuous lenalidomide maintenance treatment on people living with multiple myeloma-a single-centre, qualitative service evaluation studyCaroline Buck, Francisco Brenes Castillo, Elena Bettio, et al.
Blood|December 30, 2017
An APRIL-based chimeric antigen receptor for dual targeting of BCMA and TACI in multiple myelomaLydia Lee, Benjamin Draper, Neil Chaplin, et al.
Ebiomedicine|September 6, 2023
Self-supervised deep learning for highly efficient spatial immunophenotypingHanyun Zhang, Khalid AbdulJabbar, Tami Grunewald, et al.
Frontiers in Oncology|October 17, 2025
Current quality of life questionnaires are not relevant for assessing QOL issues in multiple myeloma patients in the era of modern therapies: results from a survey with myeloma patients and myeloma healthcare professionalsCatherine S Y Lecat, Sotirios Bristogiannis, Dipal Mehta, et al.
The Journal of General Virology|April 24, 2004
Genetic content of wild-type human cytomegalovirusAidan Dolan, Charles Cunningham, Ralph D Hector, et al.
Science Translational Medicine|April 16, 2025
Preclinical development of anti-CD21 chimeric antigen receptor T cells to treat T cell acute lymphoblastic leukemiaNicola Maciocia, Malika Hoekx, Ciaran Acuna, et al.
Pageof 6

Showing results (41-50 of 57) with videos related to

Sort By:
Pageof 6
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|June 3, 2022
The impact of COVID-19 on autologous stem cell transplantation in multiple myeloma: A single-centre, qualitative evaluation studyMarquita Camilleri, Georgios Bekris, Govundeep Sidhu, et al.
British Journal of Haematology|June 18, 2016
Evaluation of B cell maturation antigen as a target for antibody drug conjugate mediated cytotoxicity in multiple myelomaLydia Lee, Danton Bounds, Jennifer Paterson, et al.
Frontiers in Oncology|August 9, 2021
Defining Unmet Need Following Lenalidomide Refractoriness: Real-World Evidence of Outcomes in Patients With Multiple MyelomaCatherine S Y Lecat, Jessica B Taube, William Wilson, et al.
Frontiers in Immunology|March 15, 2021
Increased Immune-Regulatory Receptor Expression on Effector T Cells as Early Indicators of Relapse Following Autologous Stem Cell Transplantation for Multiple MyelomaLydia Lee, Nouf Alrasheed, Garima Khandelwal, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|July 2, 2024
The impact of continuous lenalidomide maintenance treatment on people living with multiple myeloma-a single-centre, qualitative service evaluation studyCaroline Buck, Francisco Brenes Castillo, Elena Bettio, et al.
Blood|December 30, 2017
An APRIL-based chimeric antigen receptor for dual targeting of BCMA and TACI in multiple myelomaLydia Lee, Benjamin Draper, Neil Chaplin, et al.
Ebiomedicine|September 6, 2023
Self-supervised deep learning for highly efficient spatial immunophenotypingHanyun Zhang, Khalid AbdulJabbar, Tami Grunewald, et al.
Frontiers in Oncology|October 17, 2025
Current quality of life questionnaires are not relevant for assessing QOL issues in multiple myeloma patients in the era of modern therapies: results from a survey with myeloma patients and myeloma healthcare professionalsCatherine S Y Lecat, Sotirios Bristogiannis, Dipal Mehta, et al.
The Journal of General Virology|April 24, 2004
Genetic content of wild-type human cytomegalovirusAidan Dolan, Charles Cunningham, Ralph D Hector, et al.
Science Translational Medicine|April 16, 2025
Preclinical development of anti-CD21 chimeric antigen receptor T cells to treat T cell acute lymphoblastic leukemiaNicola Maciocia, Malika Hoekx, Ciaran Acuna, et al.
Pageof 6